Global /Canada /Healthcare /Drug Manufacturers - General /TMED
chevron_leftBack
EGF Theramed Health Corp. logo

EGF Theramed Health Corp.

TMED
CSE: TMED Delayed
0.0800CAD 33%
0.0576 USD
As of 6 June 2026, EGF Theramed Health Corp. has a market cap of $666.21K USD, ranking #48867 globally and #2774 in Canada. It ranks #4341 in the Healthcare sector, and #1361 in the Drug Manufacturers - General industry.
Global Rank
48867
Country Rank
2774
Sector Rank
4341
Industry Rank
1361
Key Stats
Market Cap
$666.21KUSD
929.33K CAD
Enterprise Value
$829.44KUSD
1.15M CAD
Net Income (TTM)
-$2.21MUSD
-3.09M CAD
PB Ratio
-0.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Connor Yuen open_in_new
Website
egftheramedhealth.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
33% 33% 33% -11% -20% 23%

News

Loading...

Markets

Exchange Ticker Price
Canadian Securities Exchange
MIC: XCNQ
PRIMARY
TMED
EGF Theramed Health Corp
ISIN: CA2684692023
Shares Out.:
11.617M1 Shares Float: 11.536M2
TV:
SA:
YF:
GF:
BA:
MS:
0.0800 CAD
OTC Markets
MIC: OTCM
EVAHF
EGF Theramed Health Corp
ISIN: CA2684692023
TV:
SA:
YF:
GF:
BA:
MS:
0.0629 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About EGF Theramed Health Corp.

EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health problems in Canada. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company also explores other medical areas, including weight loss, skin care, and heart disease. EGF Theramed Health Corp. is headquartered in Vancouver, Canada.

Similar Companies

Industry: Drug Manufacturers - General (Canada)
Name
Market Cap diff.
PE
$5.39B
809K%
-
$519.8M
725.1M CAD
78K%
-
$223.22M
33K%
-
$155.46M
216.85M CAD
23K%
-
RX
$118.9M
165.86M CAD
18K%
18.5
$110.6M
154.28M CAD
17K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
114M%
38.1
JNJ
$547.28B
82M%
26.4
ABBV
$360.63B
54M%
97.4
$324.68B
256.25B CHF
49M%
19.9
AZN
$289.43B
215.59B GBP
43M%
27.6
NOVN
$277.35B
218.9B CHF
42M%
20.5
chevron_leftBack